Please Wait
Applying Filters...
menu
    • menu
    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Degludec

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    $ API Ref.Price (USD/KG) : 172,783Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 7Ryzodeg

    02 8Tresiba

    03 7Xultophy

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Ryzodeg

    Insulin Degludec

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Ryzodeg

    Denmark
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Novo Nordisk

    Insulin Degludec

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 210

    2019 Revenue in Millions : 162

    Growth (%) : 30

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Xultophy

    Insulin Degludec

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Xultophy

    Denmark
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Novo Nordisk

    Insulin Degludec

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 398

    2019 Revenue in Millions : 359

    Growth (%) : 11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Tresiba

    Insulin Degludec

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Tresiba

    Denmark
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Novo Nordisk

    Insulin Degludec

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2020 Revenue in Millions : 1,459

    2019 Revenue in Millions : 1,506

    Growth (%) : -3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Tresiba

    Insulin Degludec

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Tresiba

    Denmark
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Novo Nordisk

    Insulin Degludec

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2021 Revenue in Millions : 1,483

    2020 Revenue in Millions : 1,435

    Growth (%) : 8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Xultophy

    Insulin Degludec

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Xultophy

    Denmark
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Novo Nordisk

    Insulin Degludec

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2021 Revenue in Millions : 405

    2020 Revenue in Millions : 391

    Growth (%) : 9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Ryzodeg

    Insulin Degludec

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Ryzodeg

    Denmark
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Novo Nordisk

    Insulin Degludec

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2021 Revenue in Millions : 261

    2020 Revenue in Millions : 207

    Growth (%) : 33

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Xultophy

    Insulin Degludec

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Xultophy

    Denmark
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Novo Nordisk

    Insulin Degludec

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2022 Revenue in Millions : 410

    2021 Revenue in Millions : 405

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Ryzodeg

    Insulin Degludec

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Ryzodeg

    Denmark
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Novo Nordisk

    Insulin Degludec

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2022 Revenue in Millions : 421

    2021 Revenue in Millions : 261

    Growth (%) : 62

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Tresiba

    Insulin Degludec

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Tresiba

    Denmark
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Novo Nordisk

    Insulin Degludec

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2022 Revenue in Millions : 1,364

    2021 Revenue in Millions : 1,483

    Growth (%) : -8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Xultophy

    Insulin Degludec

    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Brand Name : Xultophy

    Denmark
    arrow
    BIO Asia-Taiwan
    Not Confirmed

    Novo Nordisk

    Insulin Degludec

    Main Therapeutic Indication : Diabetes

    Currency : USD

    2023 Revenue in Millions : 468

    2022 Revenue in Millions : 410

    Growth (%) : 15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF